Adaptimmune stock plunges after announcing Nasdaq delisting plans
Ian T. Graham, Chief Legal Officer & Corporate Secretary at Ferguson Enterprises Inc. (FERG), sold 606 shares of common stock on October 15, 2025. The sales were executed at a volume-weighted average price of $239.3266, resulting in a total transaction value of $145,031. The price for these shares ranged from $239.310 to $239.359.
On the same day, Graham also disposed of 253 shares of common stock at a price of $240.42, for a total value of $60,826. Additionally, Graham acquired 7 shares of common stock with a value of $0. These shares were received as dividend equivalents upon the vesting of Restricted Stock Units.
Following these transactions, Graham directly owns 7,714 shares of Ferguson Enterprises Inc. (FERG).
In other recent news, Ferguson Enterprises Inc. announced a $750 million senior notes offering, with the notes due in 2031 and guaranteed by Ferguson UK Holdings Limited. The offering is expected to close in September 2025, pending customary conditions. Following Ferguson’s fourth-quarter results, which exceeded expectations, several investment firms have adjusted their price targets for the company. RBC Capital raised its price target to $243, maintaining an Outperform rating, citing that the results were better than anticipated despite some market demand weakness. Wells Fargo increased its target to $275, highlighting Ferguson’s strong business model and potential for market share gains. UBS adjusted its target to $225, with a Neutral rating, while revising its earnings estimates for fiscal years 2026 to 2028. Truist Securities also raised its target to $260, noting strong growth in the non-residential segment and overall market share gains. These updates reflect analysts’ positive outlook on Ferguson’s financial performance and growth potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.